O'Connor Richard A, Anderton Stephen M
University of Edinburgh, Institute of Immunology and Infection Research, School of Biological Sciences, Kings Buildings, West Mains Road, Edinburgh EH9 3JT, UK.
Cell Immunol. 2008 Jan;251(1):8-18. doi: 10.1016/j.cellimm.2008.02.001. Epub 2008 Mar 25.
The discovery of forkhead box p3 (Foxp3) as the critical transcriptional controller of suppressive function in murine CD4(+) T regulatory (Treg) cells has allowed precise analyses of these cells in a range of immunopathological models. Recent data have revealed key roles for Foxp3+ Tregs in murine models of human organ-specific autoimmune conditions. Do these Tregs target the same autoantigens recognized by the autoaggressive T cells that need to be controlled? Under steady state conditions there may not be a need for such a shared recognition to dampen spontaneous anti-self priming in the lymphoid organs. However, when they are needed to control ongoing inflammation, Tregs recognizing autoantigens found in the diseased organ appear to have significantly stronger suppressive powers. We reflect on these observations that clearly have relevance for the translation of Treg-targeting immune therapies to human disease.
叉头框蛋白P3(Foxp3)作为小鼠CD4(+)调节性T(Treg)细胞抑制功能的关键转录调控因子的发现,使得在一系列免疫病理模型中能够对这些细胞进行精确分析。最近的数据揭示了Foxp3+ Tregs在人类器官特异性自身免疫性疾病小鼠模型中的关键作用。这些Tregs是否靶向那些需要被控制的自身攻击性T细胞所识别的相同自身抗原呢?在稳态条件下,可能不需要这种共同识别来抑制淋巴器官中的自发自身免疫启动。然而,当需要它们来控制持续的炎症时,识别患病器官中自身抗原的Tregs似乎具有明显更强的抑制能力。我们思考这些观察结果,它们显然与将针对Treg的免疫疗法转化用于人类疾病相关。